In conclusion, our results demonstrate that PI with HDAC6-selective inhibitor induces synergistic cytotoxicity in both BTZ-sensitive and BTZ-resistant MM, associated with the inactivation of MAPK, ATK, NF-κB, and STAT3 signaling pathways. Here, HDAC6 is linked to Miyoshi myopathy.